DAVID FESER: Open Payments
NPI 1801534144 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,234 in 113 payments from 21 companies in 2025. Trend: 2023 $192 · 2024 $1,326 · 2025 $2,234
Food & beverage: $2,234
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 16 | $441 |
| ABBVIE INC. | 22 | $357 |
| Novartis Pharmaceuticals Corporation | 20 | $262 |
| Janssen Biotech, Inc. | 19 | $231 |
| E.R. Squibb & Sons, L.L.C. | 5 | $193 |
| Amgen Inc. | 4 | $188 |
| UCB, Inc. | 9 | $185 |
| ConvaTec Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $42 |
| LNHC, Inc | 2 | $39 |
Products named: NEMLUVIO, SKYRIZI, TREMFYA, Sotyktu, OTEZLA, Bimzelx, RINVOQ, COSENTYX.
Industry payments across OH — which companies pay providers there.
